Rothschild & Co Asset Management US’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-442,769
| Closed | -$7.27M | – | 367 |
|
|
2019
Q4 | $7.27M | Sell |
442,769
-20,139
| -4% | -$330K | 0.08% | 270 |
|
|
2019
Q3 | $6.15M | Sell |
462,908
-4,304
| -0.9% | -$57.2K | 0.07% | 275 |
|
|
2019
Q2 | $6.58M | Buy |
467,212
+45,071
| +11% | +$635K | 0.07% | 276 |
|
|
2019
Q1 | $7.77M | Sell |
422,141
-43,413
| -9% | -$799K | 0.08% | 269 |
|
|
2018
Q4 | $12.2M | Buy |
465,554
+23,738
| +5% | +$620K | 0.15% | 227 |
|
|
2018
Q3 | $10.1M | Sell |
441,816
-8,205
| -2% | -$188K | 0.1% | 267 |
|
|
2018
Q2 | $8.57M | Sell |
450,021
-902,555
| -67% | -$17.2M | 0.09% | 276 |
|
|
2018
Q1 | $22.8M | Sell |
1,352,576
-19,515
| -1% | -$329K | 0.25% | 166 |
|
|
2017
Q4 | $20.9M | Buy |
1,372,091
+59,757
| +5% | +$908K | 0.22% | 185 |
|
|
2017
Q3 | $23.5M | Buy |
+1,312,334
| New | +$23.5M | 0.26% | 167 |
|